摘要
总结近年来紫杉醇诱导细胞凋亡机制的研究进展 ,阐述其多种可能的途径 ,为临床应用该类药物提供更好的指导。
出处
《国外医学(肿瘤学分册)》
北大核心
2000年第4期204-207,共4页
Foreign Medical Sciences (Cancer Section)
参考文献10
-
1Rakovitch E,Mellado W,Hall EJ,et al. International Journal of Radiation Oncology Biology Physics . 1999
-
2Sagata N,Watanable N,Vande Woude GF,et al. Nature . 1989
-
3Graniela Sire EA,Vikhanskaya F,Broggini M. Annals of Oncology . 1995
-
4Wahl AF,Donaldson KL,Fairchild C,et al. Nature Medicine . 1996
-
5Wu GS,El Deiry WS. Nature Medicine . 1996
-
6Fan S,Cherney B,Reinhold W,et al. Clinical Cancer Research . 1998
-
7Debernardis D,Sire EG,De Feudis P,et al. Cancer Research . 1997
-
8Jordan MA,Wendell K,Gardiner S,et al. Cancer Research . 1996
-
9Torres K,Horwitz S B. Cancer Research . 1998
-
10Haldar S,Chintapalli J,Croce CM. Cancer Research . 1996
同被引文献32
-
1Jongh FE, Wit R, Verweij J, et al. Dose-dense cisplatin/paclitaxel, a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer. Eur J Cancer, 2002,38: 2005.
-
2Urakami S, Igawa M, Kikuno N, et al. Combination chemotherapy with paclitaxel, estramustine and carboplatin for hormone refractory prostate cancer. J Urol, 2002, 168: 2444.
-
3Hiramatsu HP, Kikuchi Y, Seto H, et al. In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan(CPT-11) in combination with other anticancer drugs. Anticancer Drugs, 2000, 11:573.
-
4Gemignani ML, Hensley ML, Cohen R, et al. Paxlitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol, 2001, 80: 16.
-
5Lluch A, Ojeda B, Colomer R, et al. Doxorubicin and paclitaxel in advanced breast carcinoma: importance of prior adjuvant anthracycline therapy. Cancer, 2000, 89: 2169.
-
6Crist W, Gehan EA, Ragab AH, et al. The third intergroup rhabdomyosarcoma study. J Clin Oncol, 1995,13: 610.
-
7Shield CL, Shields JA, Honavar SG, et al. Clinical spectrum of primary ophthalmic rhabdomyosarcoma. Ophthalmology, 2001,108: 2284.
-
8Donaldson KL, Goolsby G, Kiener PA, et al. Activation of pcdc2 coincident with taxol-induced apoptosis. Cell Growth Differ, 1994, 5: 141.
-
9亓玉琴.端粒、端粒酶与肝癌[J].国外医学(肿瘤学分册),1998,25(3):165-167. 被引量:3
-
10何兴祥,王家,马龙.端粒酶的激活与肿瘤的发生[J].华人消化杂志,1998,6(12):1100-1101. 被引量:10
引证文献3
-
1高翔,杨迪生,叶招明,陶惠民,李伟栩.紫杉醇抑制胚胎型横纹肌肉瘤RD细胞株生长的实验研究[J].浙江医学,2005,27(1):6-8. 被引量:1
-
2李学源,于鲁华,齐武,曲启娟.放射治疗并口服化学药物治疗食管癌疗效观察[J].中华放射医学与防护杂志,2005,25(2):150-152. 被引量:4
-
3秦云才,亓玉琴,司君利,林静,朱菊人,刘吉勇.紫杉醇体外诱导人胃癌细胞凋亡及对端粒酶活性的影响[J].世界华人消化杂志,2001,9(9):1086-1087. 被引量:9
二级引证文献14
-
1杨曌,王惠明.基于HPV16肿瘤基因治疗载体的构建与鉴定[J].中华肿瘤防治杂志,2008,15(13):965-967.
-
2李昕,聂克.中药抑制肿瘤端粒酶活性的研究进展[J].中药新药与临床药理,2004,15(6):440-443. 被引量:1
-
3李伏娥,朱陵群,叶红军,李坚,王俊萍,吴子刚.苦参碱诱导人胃癌细胞凋亡及对端粒酶活性的影响[J].中国现代医学杂志,2005,15(12):1809-1812. 被引量:59
-
4徐国暑,陈培丰.国内抗癌中药化学研究进展[J].云南中医中药杂志,2006,27(4):47-49. 被引量:1
-
5刘晓玲,王育生,高峻,王山川.紫杉醇联合氟尿嘧啶治疗晚期胃癌31例临床观察[J].临床医药实践,2006,15(11):811-813.
-
6陈萍,施瑞华,凌亭生.磁性纳米控释紫杉醇对食管癌Eca109细胞株生长的影响[J].世界华人消化杂志,2006,14(35):3348-3352. 被引量:3
-
7王浩.^(125)I粒子不同排布方式捆绑于支架治疗晚期食管癌[J].医学研究杂志,2008,37(1):31-34. 被引量:3
-
8滕帼英,吴剑.中草药诱导人胃癌细胞凋亡可能分子机制[J].中国现代医生,2008,46(16):44-46. 被引量:2
-
9邓瑞斌.紫杉醇联合亚叶酸钙和氟尿嘧啶治疗晚期胃癌的临床观察[J].中外医疗,2008,27(15):1-2. 被引量:2
-
10杨曌,王惠明,王莉,吴玉章.基于HPV16的新型伪病毒肿瘤疫苗对Hela细胞的杀伤作用研究[J].现代肿瘤医学,2008,16(8):1263-1265.
-
1孙毅,卢贤瑜.硒抗肿瘤机制的研究进展[J].国际检验医学杂志,2006,27(11):1042-1044. 被引量:8
-
2万云峰,姚明辉.紫杉醇诱导肿瘤细胞凋亡的基因表达特性研究[J].中国药理通讯,2003,20(3):74-75.
-
3毕伟东,王成艳,冯建华.锌与细胞凋亡[J].医学理论与实践,2002,15(1):20-21. 被引量:4
-
4朱鹏举,侯旭奔,方浩.淋巴特异性酪氨酸磷酸酶抑制剂的研究进展[J].药学学报,2017,52(5):699-705. 被引量:1
-
5徐克雷.维生素D对多种器官和疾病的影响[J].中国实用内科杂志,2009,29(S2):146-148.